Literature DB >> 23669360

Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions.

Ching-Hui Huang1, Yong-Cyuan Chen, Chien-Chang Chen.   

Abstract

Cav3.2 T-type Ca(2+) channel is required for the activation of calcineurin/NFAT signaling in cardiac hypertrophy. We aimed to investigate how Cav3.2 and calcineurin interact. We found that Ca(2+) and calmodulin modulate the Cav3.2/calcineurin interaction. Calcineurin binding to Cav3.2 decreases the enzyme's phosphatase activity and diminishes the channel's current density. Phenylephrine-induced hypertrophy in neonatal cardiac myocytes is reduced by a cell-permeable peptide with the calcineurin binding site sequence. These data suggest that Cav3.2 regulates calcineurin/NFAT pathway through both the Ca(2+) influx and calcineurin binding. Our findings unveiled a reciprocal regulation of Ca(2+) signaling which contributes to our understanding of cardiac hypertrophy.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23669360     DOI: 10.1016/j.febslet.2013.04.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.

Authors:  Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

Review 2.  T-type Ca2+ channels in spermatogenic cells and sperm.

Authors:  Alberto Darszon; Arturo Hernández-Cruz
Journal:  Pflugers Arch       Date:  2014-03-06       Impact factor: 3.657

3.  Targeting intrinsically disordered regions facilitates discovery of CaV3.2 inhibitory peptides for AAV-mediated peripheral analgesia.

Authors:  Seung Min Shin; Justas Lauzadis; Brandon Itson-Zoske; Yongsong Cai; Fan Fan; Gayathri Natarajan; Wai-Meng Kwok; Michelino Puopolo; Quinn H Hogan; Hongwei Yu
Journal:  Pain       Date:  2022-04-14       Impact factor: 7.926

4.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 5.  Genetic T-type calcium channelopathies.

Authors:  Norbert Weiss; Gerald W Zamponi
Journal:  J Med Genet       Date:  2019-06-19       Impact factor: 6.318

Review 6.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

7.  The mineralocorticoid receptor leads to increased expression of EGFR and T-type calcium channels that support HL-1 cell hypertrophy.

Authors:  Katharina Stroedecke; Sandra Meinel; Fritz Markwardt; Udo Kloeckner; Nicole Straetz; Katja Quarch; Barbara Schreier; Michael Kopf; Michael Gekle; Claudia Grossmann
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

8.  T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B.

Authors:  Agustin Garcia-Caballero; Fang-Xiong Zhang; Victoria Hodgkinson; Junting Huang; Lina Chen; Ivana A Souza; Stuart Cain; Jennifer Kass; Sascha Alles; Terrance P Snutch; Gerald W Zamponi
Journal:  Mol Brain       Date:  2018-05-02       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.